Parkinson's Disease and dementia are closely linked conditions that can significantly impact cognitive function. While Parkinson's primarily affects motor functions due to the loss of dopamine-producing neurons in the brain, around 50-80% of people with Parkinson's eventually develop dementia. The dementia associated with Parkinson's Disease (PDD) often involves a range of cognitive impairments, including memory loss, confusion, and difficulty with executive functions. Unlike Alzheimer's Disease, where memory loss is typically the initial symptom, PDD may manifest with motor symptoms first before cognitive decline becomes apparent. Managing PDD involves a combination of medications to address Parkinson's symptoms and cognitive therapies to support memory and thinking skills. Research into the underlying mechanisms and treatments for PDD is ongoing, highlighting the complex interplay between motor and cognitive functions in neurodegenerative diseases.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States